2020 TTF RARE Mutations - Sands - Casting a Wide Net: The Need for Broad Molecular Testing

dbrock's picture
2020 Targeted Therapies Patient Forum - RARE Mutations Dr. Jacob Sands - Casting a Wide Net: The Need for Broad Molecular Testing
Denise Brock, Operations Director
We continue to present final videos from this highly anticipated annual event, the 2020 Targeted Therapies Patient Forum.

This event's live-online presentations and discussions were launched by our Event Chair, Luis E. Raez, MD FACP FCCP, Member of the GRACE Board of Directors, President of the Florida Society of Clinical Oncology (FLASCO), and Chief Scientific Officer & Medical Director at Memorial Cancer Institute.

This day-long event featured top oncologists in their field, presenting the most current and emerging information in targeted therapies for patients and caregivers living with lung cancer.


In this video from the Rare Mutations session from the event, Dr. Jacob Sands discusses the need for broad molecular testing.


We thank our sponsors for their support of this event! AstraZeneca, Lilly, Novartis, Takeda, Foundation Medicine, Boehringer Ingelheim, Blueprint Medicines and Genentech

Access to the full agenda can be found here: https://bit.ly/39131em

Full bios for attending faculty can be found here: https://bit.ly/2M0FVLH

To join the conversation, visit https://cancergrace.org/forum.

Video Language: 


Join the Conversation

Please feel free to offer comments and raise questions in our
discussion forums.

 Join The conversation